Skip to Main Content

Paper Details

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
Clin Pharmacol Ther
614
2015
CYP2C19, CYP2C19 genotype, CYP2D6, Serotonin, Serotonin Reuptake, citalopram, escitalopram, fluvoxamine, major depressive and anxiety disorders, paroxetine, pharmgkb, serotonin, serotonin reuptake, sertraline
Author NameAffiliation
James K HicksDepartment of Pharmacy, Cleveland Clinic, USA Genomic Medicine Institute, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Susan G LeckbandVeterans Affairs San Diego Healthcare System, University of California, Skaggs School of Pharmacy and Pharmaceutical Sciences and Department of Psychiatry
Adrián LlerenaCICAB Clinical Research Center, Extremadura University Hospital and Medical School
Stuart A ScottIcahn School of Medicine at Mount Sinai
Teri E KleinStanford University
  • 1 - 5

Datasets

Release 1.2